{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:20:49Z","timestamp":1790079649604,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000073","name":"Autism Speaks","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000073","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cincinnati Children's Hospital"},{"name":"Alzheimer's Association (IIRG)"},{"DOI":"10.13039\/100000002","name":"NIA\/National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer's Association (IIRG)"},{"name":"Indiana CTSI"},{"DOI":"10.13039\/100005337","name":"American Academy of Child and Adolescent Psychiatry","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005337","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journalofpsychiatricresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jpsychires.2014.07.011","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T07:02:21Z","timestamp":1408431741000},"page":"220-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Impact of acamprosate on plasma amyloid-\u03b2 precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker"],"prefix":"10.1016","volume":"59","author":[{"given":"Craig A.","family":"Erickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balmiki","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan K.","family":"Wink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tori L.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah K.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debomoy K.","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2014.07.011_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/jpet.112.199356","article-title":"Pharmacodynamics of selective inhibition of gamma-secretase by avagacestat","volume":"344","author":"Albright","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.07.011_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jnr.22172","article-title":"Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP\/PS1 transgenic mice","volume":"88","author":"Alley","year":"2010","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib3","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"5","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib4","series-title":"Diagnostic and statistical manual of mental disorders","author":"Aylward","year":"2000"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib5","series-title":"Diagnostic and statistical manual","author":"American_Psychiatric_Association","year":"2013"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1212\/WNL.59.2.175","article-title":"Effects of age on brain volume and head circumference in autism","volume":"59","author":"Aylward","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib7","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1212\/WNL.53.9.2145","article-title":"MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults","volume":"53","author":"Aylward","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrn1667","article-title":"From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome","volume":"6","author":"Bagni","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib9","first-page":"338","article-title":"Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis","volume":"1","author":"Bailey","year":"2008","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib10","doi-asserted-by":"crossref","first-page":"e21954","DOI":"10.1371\/journal.pone.0021954","article-title":"Rivastigmine lowers Abeta and increases sAPPalpha levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons","volume":"6","author":"Bailey","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/42257","article-title":"Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E","volume":"388","author":"Barger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1601-183X.2005.00135.x","article-title":"Therapeutic implications of the mGluR theory of fragile X mental retardation","volume":"4","author":"Bear","year":"2005","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1017\/S1461145708008584","article-title":"Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions","volume":"11","author":"Blednov","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10803-006-0205-z","article-title":"Autism spectrum phenotype in males and females with fragile X full mutation and premutation","volume":"37","author":"Clifford","year":"2007","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1025014929212","article-title":"Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised","volume":"33","author":"Constantino","year":"2003","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.290.3.337","article-title":"Evidence of brain overgrowth in the first year of life in autism","volume":"290","author":"Courchesne","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.57.2.245","article-title":"Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study","volume":"57","author":"Courchesne","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijdevneu.2005.01.003","article-title":"Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity","volume":"23","author":"Courchesne","year":"2005","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/088307389601100509","article-title":"Head circumference measurements in children with autism","volume":"11","author":"Davidovitch","year":"1996","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mcn.2009.09.013","article-title":"Fragile X mental retardation protein control of neuronal mRNA metabolism: insights into mRNA stability","volume":"43","author":"De Rubeis","year":"2010","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib23","series-title":"ADHD rating scale IV: checklists, norms, and clinical interpretation","author":"DuPaul","year":"1998"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/cap.2011.0034","article-title":"An open-label naturalistic pilot study of acamprosate in youth with autistic disorder","volume":"21","author":"Erickson","year":"2011","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s10803-010-0988-9","article-title":"Brief report: acamprosate in fragile X syndrome","volume":"40","author":"Erickson","year":"2010","journal-title":"J\u00a0autism Dev Disord"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib26","article-title":"Brief report: pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder","author":"Erickson","year":"2013","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-013-3022-z","article-title":"Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome","author":"Erickson","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2040-2392-4-21","volume":"4","author":"Fatemi","year":"2013","journal-title":"Mol Autism"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib29","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/ajmg.a.32290","article-title":"Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder","volume":"146A","author":"Garcia-Nonell","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib30","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib31","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/j.1530-0277.2008.00787.x","article-title":"Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL\/6J mice","volume":"32","author":"Gupta","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib32","series-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1530-0277.2002.tb02484.x","article-title":"Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors","volume":"26","author":"Harris","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib34","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/ajmg.a.31286","article-title":"Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP","volume":"140A","author":"Hatton","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archgenpsychiatry.2011.39","article-title":"Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years","volume":"68","author":"Hazlett","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaac.2012.07.003","article-title":"Trajectories of early brain volume development in fragile X syndrome and autism","volume":"51","author":"Hazlett","year":"2012","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib37","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1074\/jbc.273.22.14015","article-title":"Regulation of amyloid precursor protein secretion by glutamate receptors in human NTERA 2 neurons","volume":"273","author":"Jolly-Tornetta","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.a.30229","article-title":"Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors","volume":"129A","author":"Kaufmann","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00702-004-0198-8","article-title":"The yield of laboratory investigations in children with infantile autism","volume":"112","author":"Kosinovsky","year":"2005","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2008.09.026","article-title":"The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats","volume":"598","author":"Kotlinska","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0169-328X(98)00236-8","article-title":"The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells","volume":"62","author":"Lahiri","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1389450033346957","article-title":"A\u00a0critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease","volume":"4","author":"Lahiri","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jnr.490370612","article-title":"Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines","volume":"37","author":"Lahiri","year":"1994","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib44","series-title":"Paper presented at the Society of Biological Psychiatry, New Orleans, Louisiana, May 12, 2011","article-title":"Biochemical evidence for the dysregulation of Alzheimer's amyloid precursor protein (APP) expression and metabolism in fragile X syndrome (FXS) and severe autism","author":"Lahiri","year":"2011"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2013.11.004","article-title":"Lessons from a BACE1 inhibitor trial: off-site but not off base","author":"Lahiri","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.2002.tb04174.x","article-title":"Developmental expression of the beta-amyloid precursor protein and heat-shock protein 70 in the cerebral hemisphere region of the rat brain","volume":"965","author":"Lahiri","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fncel.2013.00094","article-title":"Autism as early neurodevelopmental disorder: evidence for an sAPPalpha-mediated anabolic pathway","volume":"7","author":"Lahiri","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nsmb.1815","article-title":"hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies","volume":"17","author":"Lee","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1530-0277.2008.00690.x","article-title":"Acamprosate: recent findings and future research directions","volume":"32","author":"Mann","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/neu.480250409","article-title":"Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons","volume":"25","author":"Mattson","year":"1994","journal-title":"J\u00a0Neurobiol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib51","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib52","first-page":"337","article-title":"Signaling events regulating the neurodevelopmental triad. Glutamate and secreted forms of beta-amyloid precursor protein as examples","volume":"5","author":"Mattson","year":"1998","journal-title":"Perspect Dev Neurobiol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1530-0277.2002.tb02587.x","article-title":"Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat","volume":"26","author":"Mayer","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2005.10.005","article-title":"Macrocephaly and the control of brain growth in autistic disorders","volume":"77","author":"McCaffery","year":"2005","journal-title":"Prog Neurobiol"},{"issue":"Suppl.\u00a010","key":"10.1016\/j.jpsychires.2014.07.011_bib55","first-page":"9","article-title":"Neurochemistry in the pathophysiology of autism","volume":"66","author":"McDougle","year":"2005","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib56","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s10803-011-1398-3","article-title":"Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement?","volume":"42","author":"McGrew","year":"2012","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0166-2236(93)90007-9","article-title":"Genetic and molecular advances in Alzheimer's disease","volume":"16","author":"Mullan","year":"1993","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib58","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1530-0277.1998.tb03871.x","article-title":"Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain","volume":"22","author":"Naassila","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2004.03.004","article-title":"Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network","volume":"47","author":"Pierrefiche","year":"2004","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib60","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse formation and function is modulated by the amyloid precursor protein","volume":"26","author":"Priller","year":"2006","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib61","doi-asserted-by":"crossref","first-page":"e20405","DOI":"10.1371\/journal.pone.0020405","article-title":"Increased secreted amyloid precursor protein-alpha (sAPPalpha) in severe autism: proposal of a specific, anabolic pathway and putative biomarker","volume":"6","author":"Ray","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib62","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1530-0277.2007.00569.x","article-title":"Effects of acamprosate on neuronal receptors and ion channels expressed in Xenopus oocytes","volume":"32","author":"Reilly","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0896-6273(89)90237-7","article-title":"The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion","volume":"3","author":"Schubert","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib64","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/08830738060210062201","article-title":"High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression","volume":"21","author":"Sokol","year":"2006","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib65","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0b013e3182166dc7","article-title":"Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links","volume":"76","author":"Sokol","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.59.2.184","article-title":"Brain structural abnormalities in young children with autism spectrum disorder","volume":"59","author":"Sparks","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/REVNEURO.2003.14.4.317","article-title":"Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity","volume":"14","author":"Stein","year":"2003","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-511X-12-68","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer's disease","volume":"12","author":"Tajima","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","article-title":"Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory","volume":"70","author":"Turner","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib70","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00001756-200411150-00002","article-title":"FMRP and its target RNAs: fishing for the specificity","volume":"15","author":"Veneri","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib71","doi-asserted-by":"crossref","first-page":"e35414","DOI":"10.1371\/journal.pone.0035414","article-title":"Abnormal intracellular accumulation and extracellular Abeta deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders","volume":"7","author":"Wegiel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib72","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pbio.0050052","article-title":"FMRP mediates mGluR5-dependent translation of amyloid precursor protein","volume":"5","author":"Westmark","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib73","doi-asserted-by":"crossref","first-page":"e26549","DOI":"10.1371\/journal.pone.0026549","article-title":"Reversal of fragile X phenotypes by manipulation of AbetaPP\/Abeta levels in Fmr1KO mice","volume":"6","author":"Westmark","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib74","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1523\/JNEUROSCI.4701-07.2007","article-title":"A\u00a0critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference","volume":"27","author":"Young-Pearse","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib75","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0092-8674(03)00079-5","article-title":"The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses","volume":"112","author":"Zalfa","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.jpsychires.2014.07.011_bib76","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ajmg.b.30678","article-title":"Identification of FMRP-associated mRNAs using yeast three-hybrid system","volume":"147B","author":"Zou","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614002088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614002088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T16:41:14Z","timestamp":1717260074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395614002088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":76,"alternative-id":["S0022395614002088"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.07.011","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of acamprosate on plasma amyloid-\u03b2 precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}